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Due to the relevance of hippocampal dysfunction in neurodevelopmental disor-
ders, which affect memory, cognitive abilities and behaviour, developmental studies 
may represent an important tool for the understanding of cellular and molecular phe-
nomena underlying early hippocampal damage, as well as to study possible thera-
peutic interventions, which may modify the progression of neuronal death. Since 
many findings support the neuroprotective effects of 17β-estradiol (E2) administra-
tion in different neurodevelopmental models of brain injury [1, 2], the present study 
investigates the effects of E2-pre-treatment in a model of neonatal hippocampal inju-
ry obtained by Trimethyltin (TMT) administration (6,5 mg/kg), characterized by neu-
ronal loss in CA1 and CA3 subfields, associated with astroglial and microglial activa-
tion [3, 4]. At P5 and P6 animals received two E2 doses (0.2 mg/kg i.p.) or vehicle. 
At P7 they received a single dose of TMT (6,5 mg/kg i.p.) and were euthanised 7 
days after treatment. Our data indicates that E2 administration significantly improves 
neuronal death in CA1, reduces the extent of microglial activation and restores TMT-
induced reduction of both parvalbumin- and neuropeptide Y-expressing interneurons 
in the same hippocampal region. Our results add information on the role of in vivo 
E2 administration on mechanisms involved in neuroprotection and cellular plasticity 
in the developing brain.
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